30–50% Faster in building AI Workflows? Exploring GPT-5 in Bioinformatics
August 18, 2025
·Abdullah Atia & Layla Bitar (Co-author)

First Impressions to GPT-5
The first thing most people notice is speed. Side-by-side with GPT-4o on the same prompt, GPT-5 often feels snappier in chat. Reviewers call it faster and more efficient, and OpenAI notes that its new reasoning mode can solve tasks with fewer output tokens.
There is a reason it is quicker. Under the hood, GPT-5 isn’t just one model: it ships as a family with a built-in router. You’ll see a flagship default, a deeper GPT-5 Thinking variant for heavyweight reasoning, and a Pro tier in enterprise settings. The router decides which engine runs for your prompt. If you have quick questions, it will go to the fast path; however, more complex prompts will trigger the thinking model automatically. That’s why the old “pick a model” dropdown is disappearing; routing is now part of the system.
How to Steer the Model
Even so, you still have agency. When the task is a bit more complex (protocol design, tricky stats, edge-case coding) manually selecting GPT-5 Thinking or nudging with cues like “take your time” or “think step by step” can help the router choose to run the deeper model. The router is designed to detect difficulty, but like any AI heuristic, it’s not perfect, and an explicit cue can help it choose the deeper track. This is a best-practice observation from early technical write-ups.
Other Perks of GPT-5
Context length is another quiet upgrade. GPT-5 holds far more in working memory than older models, so you can keep full papers, code, and discussion in one place without losing the thread. That’s particularly useful in health tech, where a single conversation might mix clinical guidelines, data dictionaries, and study notes.
On developer ground, GPT-5 is performs strongly in code generation. It posts state-of-the-art results on coding benchmarks like SWE-Bench Verified and Aider Polyglot, and OpenAI’s guidance emphasizes fewer tool calls and fewer tokens to reach a correct solution. This is valuable when you’re iterating pipelines or stitching analytics into a product. In short: deeper reasoning with less wasted output.
What about raw speed claims like “30–50 percent faster”? In our and others’ informal side-by-side testing with GPT-4o, GPT-5 often delivers results noticeably faster. Actual gains depend on the task and whether the router selects the faster or deeper reasoning path. Officially, OpenAI frames the improvement as efficiency: GPT-5 reaches better results with less output and smarter routing.
R&D: Real-World Evaluation
This one will land with your R&D folks: early domain experts are already stress-testing GPT-5 for experimental design and prediction. Immunologist Dr. Derya Unutmaz has been publicly sharing impressions after running hundreds of biomedical prompts, including comparisons to prior reasoning models. That kind of independent scrutiny is exactly what you want to see as you consider production use. You can check the full article from here.
A Day in the Life: GPT-5 in Bioinformatics
So what does all of this look like in bioinformatics, day to day?
Picture a normal morning: new FASTQs land in your bucket, a reviewer ping is looming, and you don’t want to dig through five wikis. You open a single thread with GPT-5 and describe the job. It doesn’t just spit code: it talks through the plan; germline or somatic, why one caller fits your data shape over another, what that implies for runtime and precision, and how to size compute without paying cloud tax.
From there the pieces fall into place. GPT-5 drafts a Nextflow profile that maps cleanly onto nf-core/sarek: alignment, QC, calling, annotation, reports. It wires MultiQC so the team can skim the right metrics, proposes VEP or ANNOVAR with a lean config for clinical relevance, and even preps an IGV session so the tricky loci are ready for a quick sanity check. You stay in one conversation, and it keeps the full context.
It feels less like “prompt and pray” and more like working alongside a senior colleague who knows your stack and your deadlines.
A Reality Check
A quick reality check is healthy here. GPT-5 will draft configurations and code, but your SOPs still rule: reference builds, joint-calling policies, filtering thresholds, and any clinical validation steps. Treat its outputs as strong templates rather than final authority, especially where compliance is in play.
From Planning to Production: Enter Bion
And that’s where the handoff begins.
While GPT-5 helps you plan, explain, and scaffold the work, Bion, a multi-agent biomedical system, developed by Bionl, helps you operationalize it. Bion takes those AI-assisted conversations and turns them into reproducible, real-world workflows inside your environment.
Bion’s orchestrator agent coordinates sub-agents to generate runnable scripts. Its filesystem agent reads your directory and metadata to align paths and inputs, and its backend agent executes directly in your live notebook. No switching tabs. No copying code.
You approve every step, tweak as needed, and keep full visibility.
We’re building toward deeper automation: stronger policy checks and richer audit views. But today, Bion’s value is simple and honest: it reduces glue work, keeps everything in one place, and makes it easier to move from a GPT-5 conversation to executed steps you can inspect and reuse.
Our motto is: You do the science; we make it seamless.
🔗 Sign up, and try Bion yourself today!
Related Posts
- Bioinformatics
How will Large Language Models (LLMs) Transform Biomedical Research?
Large language models, such as GPT-3, have the potential to revolutionize biomedical research by helping scientists quickly and accurately analyze vast amounts of data.
Jan 2023

Ahmad Jadallah
- Bioinformatics
- Research
The Revolution of Drug Discovery: The Impact of Artificial Intelligence
In the ever-evolving landscape of healthcare, drug discovery remains one of the most critical and complex processes. The development of new drugs is essential for tackling diseases and improving the quality of life. However, traditional drug discovery methods are often time-consuming and costly. This is where Artificial Intelligence (AI) steps in, offering innovative solutions to streamline and enhance drug discovery.
Jun 2023
